Estrella Immunopharma Insider Form 3 Filed
A Form 3 for Estrella Immunopharma, filed by Cynthia Pussinen for Oct. 25, was reported as filed on Nov. 3.
Related stories
Barclays Runs Sale Process for Exeter Finance’s Nonprime Auto Loans
Barclays is running a sale process for up to $1 billion of Exeter Finance’s nonprime auto loans.
M impact | EQUITY | Nov 03, 2026, 06:30 PM UTC
ZNB: trading halted on Nasdaq — volatility pause (1:23 PM ET)
Nasdaq halted trading in ZNB (volatility pause) at 1:23 PM ET.
L impact | EQUITY | Nov 03, 2026, 06:30 PM UTC
US session market picture: S&P 500 +0.53%, Nasdaq 100 +0.87%; EUR/USD +0.09%, WTI -0.43%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.53 percent, Nasdaq futures is up 0.87 percent, Dow futures is down 0.27 percent and Russell futures is up 0.69
M impact | EQUITY | Nov 03, 2026, 06:30 PM UTC
American Honda Sales Rise 8% in October
Honda Motor's American Honda unit reported an 8% sales rise in October.
L impact | EQUITY | Nov 03, 2026, 06:29 PM UTC
Campine Agrees to Acquire Minority Stake in Thailand’s Green Tech Antimony
M impact | EQUITY | Nov 03, 2026, 06:29 PM UTC
Beta Technologies Raises Annual Revenue Outlook; Shares Rise 15%
Beta Technologies raised its annual revenue outlook and cited a regulatory milestone allowing demonstration flights with prospective customers. Its stock rose 15% to $23.53.
M impact | EQUITY | Nov 03, 2026, 06:27 PM UTC